Envoy Medical Inc
COCHW0.042USD
+0.003+7.20%
Close （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Envoy Medical Inc Company
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
Envoy Medical Inc Info
Ticker SymbolCOCHW
Company nameEnvoy Medical Inc
IPO dateMar 02, 2021
CEOMr. Brent T. Lucas
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address4875 White Bear Parkway
CityWHITE BEAR LAKE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code55110
Phone16513618000
Websitehttps://www.envoymedical.com/
Ticker SymbolCOCHW
IPO dateMar 02, 2021
CEOMr. Brent T. Lucas
Company Executives of Envoy Medical Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Mr. Charles R. Brynelsen
Mr. Charles R. Brynelsen
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Potashnick
Mr. Robert Potashnick
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Michael Crowe
Mr. Michael Crowe
Independent Director
Independent Director
--
--
Ms. Susan J. Kantor
Ms. Susan J. Kantor
Independent Director
Independent Director
--
--
Ms. Mona Patel
Ms. Mona Patel
Independent Director
Independent Director
--
--
Mr. Brent T. Lucas
Mr. Brent T. Lucas
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Janis Smith-Gomez
Ms. Janis Smith-Gomez
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
70
6.64M
0.00%
-1.43M
2025Q3
77
6.64M
0.00%
+215.36K
2025Q2
78
6.46M
0.00%
+268.15K
2025Q1
79
6.19M
0.00%
-2.48M
2024Q4
85
6.80M
0.00%
-132.66K
2024Q3
90
6.94M
0.00%
-176.11K
2024Q2
94
7.12M
0.00%
-660.66K
2024Q1
94
7.78M
0.00%
-22.09M
2023Q4
93
7.87M
0.00%
+1.34M
2023Q3
90
6.53M
0.00%
-1.61M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Clear Street Group Inc
431.14K
0%
+431.14K
--
Sep 30, 2025
TD Securities, Inc.
534.93K
0%
-100.00
-0.02%
Sep 30, 2025
D. E. Shaw & Co., L.P.
113.43K
0%
--
--
Sep 30, 2025
Aristeia Capital, L.L.C.
1.06M
0%
--
--
Sep 30, 2025
Sandia Investment Management LP
589.89K
0%
--
--
Sep 30, 2025
Walleye Trading, LLC
153.82K
0%
-138.04K
-47.30%
Sep 30, 2025
Clear Street LLC
301.37K
0%
-200.00
-0.07%
Jun 30, 2025
Polar Asset Management Partners Inc.
297.10K
0%
--
--
Sep 30, 2025
BNP Paribas Securities Corp. North America
283.33K
0%
--
--
Sep 30, 2025
Bracebridge Capital, LLC
262.16K
0%
--
--
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Envoy Medical Inc?
The top five shareholders of Envoy Medical Inc are:
Clear Street Group Inc holds 431.14K shares, accounting for 0.00% of the total shares.
TD Securities, Inc. holds 534.93K shares, accounting for 0.00% of the total shares.
D. E. Shaw & Co., L.P. holds 113.43K shares, accounting for 0.00% of the total shares.
Aristeia Capital, L.L.C. holds 1.06M shares, accounting for 0.00% of the total shares.
Sandia Investment Management LP holds 589.89K shares, accounting for 0.00% of the total shares.
Clear Street Group Inc holds 431.14K shares, accounting for 0.00% of the total shares.
TD Securities, Inc. holds 534.93K shares, accounting for 0.00% of the total shares.
D. E. Shaw & Co., L.P. holds 113.43K shares, accounting for 0.00% of the total shares.
Aristeia Capital, L.L.C. holds 1.06M shares, accounting for 0.00% of the total shares.
Sandia Investment Management LP holds 589.89K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Envoy Medical Inc?
The top three shareholder types of Envoy Medical Inc are:
Other
Other
How many institutions hold shares of Envoy Medical Inc (COCHW)?
As of 2025Q4, 70 institutions hold shares of Envoy Medical Inc, with a combined market value of approximately 6.64M, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Envoy Medical Inc?
In --, the -- business generated the highest revenue for Envoy Medical Inc, amounting to -- and accounting for --% of total revenue.
